Maureen Galmes-Spit
Company: Laigo Bio
Job title: VP Research
Seminars:
SureTACsTM: Beyond Blocking Membrane Proteins 8:30 am
Membrane-bound E3 ligases can be repurposed for the targeted degradation of disease-driving cell surface proteins Laigo Bio’s TED-I screening platform is essential to identify optimal E3-target pairs with highest degrader potency SureTACsTM: bispecific antibodies that induce cell surface removal and target degradation in a tissue- and disease-specific mannerRead more
day: Post-Conference Focus Day
Chair’s Closing Remarks 4:00 pm
day: Post-Conference Focus Day